Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes

NCT04079881 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Loss of funding

Conditions

Type 1 Diabetes
Hyperglycemia, Postprandial

Interventions

DRUG: Insulin

Sponsor

Washington University School of Medicine